In vitro assessments of antimicrobial activity.
Ended Awarded Last action
- Contract number
- 75N93019F00131
- Awardee
-
Element Materials Technology Iowa City Inc. UEI GAJDDSFFPD89
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $76,000
Award facts
- Opportunity
-
- RFPNIAIDDMIDNIHAI2017091 Solicitation number
- In Vitro Assessments of Antimicrobial Activity Award Notice · Posted Nov 14, 2017
- Contract value 100% obligated
- $76,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Liberty, IA 52317, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Funding Only Action | $73,500 | |
| Original award | $2,500 |
About this award
Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, was awarded a $76,000 delivery order on January 11, 2019, under the In Vitro Assessments of Antimicrobial Activity (IVAAA) indefinite-delivery/indefinite-quantity contract vehicle. The National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, funded this civilian contract to conduct in vitro assessments of antimicrobial activity against bacterial species. Specifically, JMI Laboratories will determine the in vitro inhibitory effect of experimental antibacterial substances through minimum inhibitory concentration (MIC) and IC90 measurements. The contract utilizes firm fixed-price pricing with no small business set-aside designation and is scheduled for completion by June 30, 2020, with performance conducted at JMI Laboratories' facility in North Liberty, Iowa.
JMI Laboratories, a for-profit Subchapter S Corporation specializing in microbiology and antimicrobial resistance testing, has established itself as a key federal contractor for NIAID and other HHS agencies since 2016. The company's expertise in conducting antimicrobial resistance research and drug discovery supports the federal government's efforts to address critical public health challenges related to antimicrobial resistance. This delivery order represents one of multiple awards JMI Laboratories has received under the IVAAA contract vehicle, reflecting the company's demonstrated capability in performing sophisticated laboratory assessments that inform regulatory and research decisions regarding experimental antibacterial compounds.
Quick answers
Who was awarded contract 75N93019F00131?
75N93019F00131 was awarded to Element Materials Technology Iowa City Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on January 11, 2019.
How much is contract 75N93019F00131 worth?
The government has obligated $76,000 on 75N93019F00131.
Is contract 75N93019F00131 an order under another contract?
Yes. 75N93019F00131 is a delivery order under 75N93019D00011, an indefinite delivery contract, on In Vitro Assessments of Antimicrobial Activity (IVAAA).
Was contract 75N93019F00131 competed?
The extent of competition for 75N93019F00131 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award